Gvoke™ (glucagon) – New drug approval
September 10, 2019 - Xeris Pharmaceuticals announced the FDA approval of Gvoke (glucagon), for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above.
Download PDF
